𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients

✍ Scribed by Heinrich Iro; Frank Waldfahrer

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
97 KB
Volume
83
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

The fifth edition of the TNM classification contains a number of changes concerning head and neck tumors. The division of Stage IV tumors into three subcategories marks a significant expansion of the stage grouping procedure.

METHODS.

In a retrospective study, the clinical courses of 3247 patients with carcinoma of the oral cavity, the oro-and hypopharynx, the larynx, the salivary glands, and the maxillary sinus were comparatively evaluated according to the fourth and fifth editions of the TNM classification agreed upon by the International Union Against Cancer and the American Joint Committee on Cancer. The particular aim of this study was to test the prognostic relevance of the subdivision of Stage IV, especially for mucosal carcinoma.

RESULTS.

In classifying the primary tumor, the most extensive changes were noted for supraglottic and salivary gland tumors. On the basis of the fourth edition of the TNM classification, the following recurrence free 5-year survival rates for 3033

πŸ“œ SIMILAR VOLUMES

Pharmacodynamic evaluation of temsirolim
Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma
✍ Oleksandr Ekshyyan; Glenn M. Mills; Timothy Lian; Nazanin Amirghahari; Xiaohua R πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 244 KB

## Abstract ## Background: Activation of the mammalian target of rapamycin (mTOR) pathway in surgical margins of head and neck squamous cell carcinoma (HNSCC) is a predictor of recurrence and patients with minimal residual disease may benefit from adjuvant therapy with temsirolimus, an mTOR inhibi

CT of the chest and abdomen in patients
CT of the chest and abdomen in patients with newly diagnosed head and neck squamous cell carcinoma
✍ Harri T. Keski-SΓ€ntti; Antti T. O. Markkola; Antti A. MΓ€kitie; Leif J. J. BΓ€ck; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Background: The benefits of ct scanning of the chest and abdomen as a routine screening method for patients with newly diagnosed head and neck squamous cell carcinoma (hnscc) remain unclear. ## Methods: Consecutive patients with a primary hnscc (t classification, t2-t4) and or regionally metas

Final report of a phase II evaluation of
Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck : An Eastern Cooperative Oncology Group trial (PA390)
✍ Arlene A. Forastiere; Darleen Shank; Donna Neuberg; Samuel G. Taylor IV; Ronald πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.